Merger13 May 2026, 11:12 am
Kobo Biotech: NCLT Approves Resolution Plan
AI Summary
The National Company Law Tribunal (NCLT) has approved the resolution plan submitted by Beaufond Industries Limited for Kobo Biotech Limited. The resolution plan was initially approved by the Committee of Creditors on March 17, 2026, and subsequently submitted to the NCLT. As per the last audited financial statements, Kobo Biotech's net worth was ₹132.91 crores and total assets were ₹71.39 crores as of March 31, 2024. Beaufond Industries' net worth was ₹333.18 crores as of March 31, 2025, which will be merged with Kobo Biotech as part of the approved resolution plan.
Key Highlights
- NCLT approved Beaufond Industries' resolution plan for Kobo Biotech on May 11, 2026.
- Kobo Biotech's net worth as of March 31, 2024, was ₹132.91 crores.
- Beaufond Industries' net worth as of March 31, 2025, was ₹333.18 crores.
- Financial creditors will assign debt and security interests to the Resolution Applicant upon payment.
- Kobo Biotech will continue to own its assets until the merger and demerger are complete.
Price Impact
More from KOBO